Sang Eun Nam1, Bum Sik Bang2, Eun Kyoung Lee3, Jung Youp Sung4, Keun Yeong Song5, Young Bum Yoo1, Dong Wook Park6, Jae Hong Kim7. 1. Department of Surgery, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea. 2. Soo Women's Hospital, Suwon, Gyeonggi, Korea. 3. Vievis NAMUH Hospital, Seoul, Korea. 4. BBC Plastic Surgery Clinic, Changwon, Korea. 5. Department of Breast Surgery, Gwangju Suwan Hospital, Gwangju, Korea. 6. Venus Women's Clinic, Seoul, Korea. 7. The W Clinic, 9F Kukdong B/D, 596 Gangnam-daero, Gangnam-gu, Seoul, 06626, Korea. stenka@hanmail.net.
Abstract
BACKGROUND: We conducted this study to describe the feasibility of high-resolution ultrasound (HRUS) in characterizing a breast implant in patients receiving an implant-based augmentation mammaplasty. METHODS: The current study was conducted in a total of 612 patients (n =6 12) receiving an implant-based augmentation mammaplasty at other hospitals between August 31, 2017 and August 31, 2020. Of these, 136 patients (n = 136; 272 breasts) receiving reoperation were included in the current study. We compared between the patients' subjective awareness of a breast implant and its HRUS findings and an agreement between HRUS findings of a breast implant and its findings at reoperation. RESULTS: The proportion of the patients receiving a silicone gel-filled breast implant was increased from 65.44% (89/136) to 81.61% (111/136) on HRUS. Moreover, HRUS was effective in identifying a manufacturer of the device. CONCLUSIONS: In conclusion, our results indicate that HRUS is feasible in characterizing a breast implant in patients receiving an implant-based augmentation mammaplasty. But further prospective, large-scale studies are warranted to corroborate our results. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors. www.springer.com/00266 .
BACKGROUND: We conducted this study to describe the feasibility of high-resolution ultrasound (HRUS) in characterizing a breast implant in patients receiving an implant-based augmentation mammaplasty. METHODS: The current study was conducted in a total of 612 patients (n =6 12) receiving an implant-based augmentation mammaplasty at other hospitals between August 31, 2017 and August 31, 2020. Of these, 136 patients (n = 136; 272 breasts) receiving reoperation were included in the current study. We compared between the patients' subjective awareness of a breast implant and its HRUS findings and an agreement between HRUS findings of a breast implant and its findings at reoperation. RESULTS: The proportion of the patients receiving a silicone gel-filled breast implant was increased from 65.44% (89/136) to 81.61% (111/136) on HRUS. Moreover, HRUS was effective in identifying a manufacturer of the device. CONCLUSIONS: In conclusion, our results indicate that HRUS is feasible in characterizing a breast implant in patients receiving an implant-based augmentation mammaplasty. But further prospective, large-scale studies are warranted to corroborate our results. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors. www.springer.com/00266 .
Authors: Juan M Colazo; Brian C Evans; Angel F Farinas; Salam Al-Kassis; Craig L Duvall; Wesley P Thayer Journal: Tissue Eng Part B Rev Date: 2019-08 Impact factor: 6.389
Authors: Andrew L Blount; Matthew D Martin; Kyle D Lineberry; Nicolas Kettaneh; David R Alfonso Journal: Aesthet Surg J Date: 2013-05 Impact factor: 4.283
Authors: Jung Youp Sung; Jeong Pil Jeong; Dong Seung Moon; Min Soo Kim; Ho Chan Kim; Woo Sik Choi; Keun Yeong Song; Hye Jin Kim; Hyung Guhn Lim; Jae Hong Kim Journal: Plast Reconstr Surg Glob Open Date: 2019-12-24